• Norovirus Exploits NINJ1 for Selective NS1 Protein Secretion

  2026-04-25

  This study uncovers how murine norovirus hijacks the host membrane protein NINJ1 to selectively secrete its NS1 protein, revealing a previously unrecognized pathway for controlled protein release during viral infection. The findings reshape our understanding of regulated plasma membrane rupture and open new avenues for dissecting cell death and secretion mechanisms in viral and cancer contexts.

• rTMS Promotes Amyloid Clearance via Cx3cl1-Cx3cr1 Axis in AD

  2026-04-24

  This study uncovers how repetitive transcranial magnetic stimulation (rTMS) enhances cognitive recovery in Alzheimer's disease by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 signaling axis, which stimulates microglial amyloid beta clearance. These findings provide mechanistic insight that informs both non-invasive therapeutic strategies and the development of research workflows for probing amyloid pathology.

• Amyloid Beta-Peptide (1-40) (human): Applied Workflows & Inn

  2026-04-24

  Amyloid Beta-Peptide (1-40) (human) unlocks reproducible, disease-relevant modeling of amyloid aggregation, neurotoxicity, and microglial signaling in Alzheimer’s research. Discover protocol-anchored workflows, advanced applications, and troubleshooting strategies that leverage APExBIO’s rigorously validated peptide for next-generation neuroscience assays.

• CYP and MAO Pathways in Sumatriptan Metabolism: Novel Insigh

  2026-04-23

  This article analyzes the recent re-examination of sumatriptan metabolism, revealing new evidence for cytochrome P450 (CYP) involvement in addition to the established monoamine oxidase A (MAO A) route. These findings have direct implications for pharmacokinetic studies and drug interaction research in neurodegenerative and central nervous system contexts.

• Maraviroc (UK-427857): Applied Workflows for CCR5-Targeted R

  2026-04-23

  Maraviroc (UK-427857) from APExBIO stands at the forefront of CCR5-targeted research, bridging HIV-1 entry inhibition with emerging strategies for inflammation and rheumatoid arthritis models. This article translates recent breakthrough findings into actionable protocols and troubleshooting guidance, maximizing reproducibility for advanced assay design.

• Indometacin Sodium: Applied Workflows in Inflammation Assays

  2026-04-22

  Indometacin Sodium Trihydrate, a high-purity NSAID from APExBIO, empowers rigorous inflammation and neuroregeneration research through robust inhibition of COX-1/2 and targeted modulation of signaling pathways. This article translates recent advances and detailed protocols into actionable workflows, troubleshooting solutions, and comparative insights for assay-driven scientists.

• Amorolfine Hydrochloride: Advanced Insights into Fungal Memb

  2026-04-22

  Explore how Amorolfine Hydrochloride, a powerful antifungal reagent, drives next-generation research on fungal membrane integrity, stress adaptation, and ploidy limits. Discover unique scientific perspectives and protocol insights for antifungal assay optimization.

• Translational Leverage: FK866 (APO866) in NAMPT-Driven Oncol

  2026-04-21

  This thought-leadership article deciphers the mechanistic and strategic edge of FK866 (APO866), a non-competitive NAMPT inhibitor, for translational researchers targeting cancer metabolism. By blending robust biological rationale, clinical insights, and competitive context, we illuminate how FK866 enables data-driven advances in hematologic and solid tumor models, particularly acute myeloid leukemia (AML) and ovarian cancer with RAS/PI3K mutations. Featuring practical protocol guidance and actionable outlooks, this piece escalates discussion beyond traditional product pages, mapping the path from bench to bedside.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition in Alzhei

  2026-04-21

  Lanabecestat (AZD3293) sets a new standard for Alzheimer's disease research with its potent, blood-brain barrier-penetrant BACE1 inhibition and validated synaptic safety profile. This article delivers actionable protocols, troubleshooting strategies, and workflow optimizations to empower reliable amyloid-beta modulation using APExBIO’s Lanabecestat in preclinical models.

• Neurotensin: Precision Neurotensin Receptor 1 Activator for

  2026-04-20

  Unlock the potential of Neurotensin as a rigorously validated tool for dissecting GPCR trafficking and miRNA regulation in gastrointestinal research. This guide provides actionable workflows, advanced troubleshooting, and integration of the latest spectral analysis advances to ensure robust, reproducible results.

• D-Luciferin Potassium Salt: Elevating Bioluminescence Imagin

  2026-04-20

  D-Luciferin (potassium salt) enables ultra-sensitive, real-time in vivo and in vitro bioluminescence detection, streamlining tumor cell tracking and quantitative luciferase assays. Discover protocol enhancements and troubleshooting strategies that maximize signal consistency and experimental reproducibility.

• Amyloid β-Peptide (1-42): Mechanisms and Advanced Assay Stra

  2026-04-19

  Explore the multifaceted roles of Amyloid β-Peptide (1-42) in Alzheimer's disease research. This article unveils new insights into Aβ42 peptide neurotoxicity, assay design, and ion channel modulation, offering a distinct and practical guide for advanced neuroscience investigations.

• Tetraethylammonium Chloride: Potassium Channel Blocker Profi

  2026-04-18

  Tetraethylammonium chloride (TEAC) is a validated potassium channel blocker used in ion conduction and vascular studies. TEAC’s dual-site mechanism enables precise interrogation of K+ channel function, supporting both pharmacological and physiological research. Clinical and experimental data define its specificity and application boundaries.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-04-17

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides sensitive, specific detection of goat immunoglobulins in fluorescence-based immunodetection workflows, such as ICC, IHC, flow cytometry, and ELISA. Researchers should use this antibody strictly within validated immunodetection protocols and avoid unsupported cross-domain applications.

• Streamlining Bitespiramycin: Targeted Gene Deletion Yields P

  2026-04-16

  This study reports the successful construction of a Streptomyces spiramyceticus strain producing exclusively 400-isovalerylspiramycin I by in-frame partial deletion of the 3-O-acyltransferase (sspA) gene. The work simplifies the composition of bitespiramycin, a clinically relevant acetoxy-substituted macrolide antibiotic, with implications for improved manufacturing and quality control.

380 records 9/26 page Previous Next First page 上5页 678910 下5页 Last page